Название продукции:2-Chloro-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one

IUPAC Name:2-chloro-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one

CAS:1449598-86-0
Молекулярная формула:C8H4ClFN2O
Чистота:95%+
Номер в каталоге:CM337294
Молекулярная масса:198.58

Упаковочная единица Доступно для заказа Цена ($) Количество
CM337294-1g in stock ǫŞǫ
CM337294-10g in stock Ȗƥƥȅ
CM337294-100g in stock ȯƛȯȅ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:1449598-86-0
Молекулярная формула:C8H4ClFN2O
Точка плавления:-
Smiles-код:O=C1C=C(Cl)N=C2N1C=C(F)C=C2
Плотность:
Номер в каталоге:CM337294
Молекулярная масса:198.58
Точка кипения:
Номер Mdl:MFCD28659052
Хранение:

Category Infos

Column Infos

Risdiplam
As the first approved small molecule splicing modifier drug, Risdiplam (Evrysdi) is granted approval by the European Commission to expand the EU marketing authorization. This extension now includes infants with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies from birth to below two months. Type 1 spinal muscular atrophy (SMA) is a rare, progressive neuromuscular disease and a leading genetic factor of infant mortality, that is caused by low levels of functional survival of motor neuron (SMN) protein. Risdiplam modifies SMN2 pre-messenger RNA splicing and increases levels of functional SMN protein in both the central nervous system and peripheral organs.